Related Experiment Video
Updated: May 4, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
Stroke-SCORE: Personalizing Acute Ischemic Stroke Treatment to Improve Patient Outcomes
Jessica Seetge1, Balázs Cséke2, Zsófia Nozomi Karádi1
1Stroke Unit, Department of Neurology, University of Pécs, 7624 Pécs, Hungary.
Insights
A new tool, Stroke-SCORE, personalizes acute ischemic stroke (AIS) treatment by predicting patient outcomes. This data-driven approach optimizes interventions like thrombolysis and mechanical thrombectomy for better results.
Area of Science:
- Neurology
- Clinical Medicine
- Biostatistics
Background:
- Acute ischemic stroke (AIS) is a primary cause of long-term disability and mortality globally.
- Current AIS treatment protocols are often standardized, lacking personalization based on individual patient characteristics.
- There is a need for data-driven tools to guide individualized treatment decisions in AIS management.
Purpose of the Study:
- To introduce the Stroke-SCORE (Simplified Clinical Outcome Risk Evaluation), a predictive tool for personalized AIS management.
- To provide data-driven, individualized recommendations for optimizing treatment strategies in AIS patients.
- To improve patient outcomes by tailoring interventions based on risk stratification.
Main Methods:
- Retrospective analysis of 793 AIS patients (February 2023-September 2024).
- Logistic regression identified age, NIHSS score, and pre-mRS as predictors of 90-day unfavorable outcomes (mRS > 2).
- Internal validation using ROC analysis and calibration assessed predictive performance.
Main Results:
- The Stroke-SCORE showed a moderate positive correlation with unfavorable 90-day outcomes (OR=0.70, p<0.001).
- The model achieved an AUC of 0.86, with 79% sensitivity, 81% specificity, and 80% overall accuracy.
- Simulations demonstrated that Stroke-SCORE-guided personalized treatment significantly reduced unfavorable outcomes.
Conclusions:
- The Stroke-SCORE is a practical, data-driven tool with strong predictive performance for personalizing AIS treatment.
- It effectively stratifies patients to guide decisions on thrombolysis, mechanical thrombectomy, or standard care.
- External, multicenter prospective validation is recommended to confirm its real-world applicability.
Abstract:
Background/Objectives: Acute ischemic stroke (AIS) is a leading cause of disability and mortality worldwide. Despite advances in interventions such as thrombolysis (TL) and mechanical thrombectomy (MT), current treatment protocols remain largely standardized, focusing on general eligibility rather than individual patient characteristics. To address this gap, we introduce the Stroke-SCORE (Simplified Clinical Outcome Risk Evaluation), a predictive tool designed to personalize AIS management by providing data-driven, individualized recommendations to optimize treatment strategies and improve patient outcomes. Methods: The Stroke-SCORE was derived using retrospective data from 793 AIS patients admitted to the University of Pécs (February 2023-September 2024). Logistic regression analysis identified age, National Institutes of Health Stroke Scale (NIHSS) score at admission, and pre-morbid modified Rankin Scale (pre-mRS) score as key predictors of unfavorable outcomes at 90 days (defined as modified Rankin Scale [mRS] score > 2). Based on these predictors, a simplified risk score was developed to stratify patients into low-, moderate-, and high-risk groups, guiding treatment decisions on TL, MT, combination therapy (TL + MT), or standard care (SC). Internal validation was performed to assess the model's predictive performance via receiver operating characteristic (ROC) analysis and isotonic regression calibration with bootstrapping. Results: The Stroke-SCORE was moderately positively correlated with a 90-day mRS score > 2 (odds ratio [OR] = 0.70, 95% confidence interval [CI]: 0.58-0.83, p < 0.001), with an area under the curve (AUC) of 0.86, a sensitivity and specificity of 79% and 81%, respectively, and an overall accuracy of 80%. Simulations indicated that personalized treatment guided by the Stroke-SCORE significantly reduced unfavorable outcomes. Conclusions: The Stroke-SCORE demonstrates strong predictive performance as a practical, data-driven approach for personalizing AIS treatment decisions. In the future, external, multicenter prospective validation is needed to confirm its applicability in real-world settings.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Atherosclerosis IV: Nursing Management
Stroke: Introduction and Types
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction

